...
首页> 外文期刊>Asian Pacific Journal of Cancer Prevention >Willingness to Pay for Colorectal Cancer Screening and Effect of Copayment in Southern Thailand
【24h】

Willingness to Pay for Colorectal Cancer Screening and Effect of Copayment in Southern Thailand

机译:泰国南部大肠癌筛查的支付意愿和共付额的影响

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: The incidence rate of colorectal cancer in Thailand is increasing. Hence, the nationwide screeningprogramme with copayment is being considered. There are two proposed screening alternatives: annual fecalimmunochemical test (FIT) and once-in-10-year colonoscopy. A copayment for FIT is 60 Thai baht (THB) per test(≈ 1.7 USD); a copayment for colonoscopy is 2,300 THB per test (≈ 65.5 USD). Methods: The willingness to pay(WTP) technique, which is theoretically founded on a cost-benefit analysis, was used to assess an effect of copayment onthe uptake. Subjects were patients aged 50-69 years without cancer or screening experience. WTP for the proposedtests was elicited. Results: Nearly two thirds of subjects were willing to pay for FIT. Less than half of subjects werewilling to pay for colonoscopy. Among them, median WTP for both tests was greater than the proposed copayments.In a probit model, knowing CRC patient and presence of companion were associated with non-zero WTP for FIT.Presence of companion, female, and family history of cancer were associated with non-zero WTP for colonoscopy.After adjustment for starting price in the linear model, marital status, drinking behavior, and risk attitude were associatedwith WTP. None of factors was significant for colonoscopy. Uptake decreased as levels of copayment increased.At proposed copayments, the uptake rates of 59.8% and 21.6% were estimated for colonoscopy and FIT respectively.The demand for FIT was price inelastic; the demand for colonoscopy was price elastic. Estimates of optimal copaymentwere 62.1 THB for FIT and 460.2 THB for colonoscopy. At the optimal copayment, uptake rates would be 59.8%for FIT and 42.3% for colonoscopy.Conclusion(s): More subjects were willing to pay for FIT than for colonoscopy(59.0% versus 46.5%). The estimated uptake rates were 59.8% and 21.6% for colonoscopy and FIT at the proposedcopayments.
机译:背景:泰国大肠癌的发病率正在上升。因此,正在考虑采用共付额的全国性筛查计划。建议使用两种筛选方法:年度粪便免疫化学测试(FIT)和每10年一次的结肠镜检查。 FIT的共付额为每项测试60泰铢(≈1.7美元);每次结肠镜检查的共付额为2,300泰铢(约合65.5美元)。方法:理论上建立在成本效益分析基础上的支付意愿(WTP)技术用于评估共付额对摄取的影响。受试者是年龄在50-69岁之间,没有癌症或没有筛查经验的患者。引发了建议测试的WTP。结果:将近三分之二的受试者愿意为FIT付费。不到一半的受试者愿意为结肠镜检查付费。其中,两项测试的WTP中位数均高于建议的共付额。在概率模型中,了解CRC患者和伴侣的存在与FIT的非零WTP相关联,伴侣,女性和癌症家族史的存在相关在调整线性模型的起始价后,婚姻状况,饮酒行为和危险态度与WTP相关。没有任何因素对结肠镜检查有意义。随着共付额水平的提高,摄取量下降。在提议的共付额下,结肠镜检查和FIT的摄取率分别估计为59.8%和21.6%。结肠镜检查的需求具有价格弹性。 FIT的最佳共付额估计为62.1 THB,结肠镜检查为460.2 THB。在最佳共付额下,FIT的摄取率为59.8%,结肠镜检查的摄取率为42.3%。结论:愿意为FIT付费的受试者比结肠镜检查的多(59.0%对46.5%)。在建议的共付额下,结肠镜检查和FIT的估计摄取率为59.8%和21.6%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号